Needle Free Devices Market size is projected to witness significant growth during 2022-2028, registering a considerable CAGR in the duration. Growing prevalence of respiratory diseases like asthma and lifestyle diseases like diabetes, cardiovascular diseases, and pulmonary diseases are the primary factors attributing to the needle free devices market expansion. Needle free devices are portable injectors that inject substances like fillers into the body using high pressure. These devices are highly efficient and require fewer resources, thus a better alternative to conventional needle vaccines.
Driven by their non-invasive and painless injecting process, these devices are gaining popularity among children, the elderly, and those with trypanophobia. Increasing technological evolution for drug delivery to offer better and improved products will propel industry growth. For example, recently on November 11, 2021, a team of New Zealand-based scientists came up with a modified version of the jet injector that is capable of extracting as opposed to injecting. This needle free technology could be a potential breakthrough for diabetic patients who are required to prick their fingers numerous times in a single day.
These devices are also ideal for self-drug administration and do not require expertise. Needle free devices have significantly reduced the chances of injury and transmission of diseases like HIV, Hepatitis, AIDS among health and cleanliness workers. These factors will foster the needle free devices industry share in the forecast timeframe.
Under the technology segment, inhaler technology is poised to bring substantial gains to the needle free devices market owing to the several benefits that the product offers. Inhalers provide immediate medication to people with severe airways diseases like asthma, chronic inflammatory lung diseases, and COPD. They are lightweight, concise, portable, easy to use, provide quick and effective relief. These factors may push the product demand in the projected timeframe.
Hospitals may emerge as a major end-use segment for needle free devices in the forthcoming years, driven by the growing geriatric population and people with severe health issues that need hospitalization for intensive treatment. Moreover, these devices are super-efficient and have significantly reduced the biohazardous waste production in hospitals. Considerable decline in sharps injuries in hospital cleaning staff will augment the segmentation growth in the coming years.
North America needle free devices market is expected to come up as a significant growth ground driven by the upsurge in the diabetic population across the region. Other factors like increasing health awareness among people leading to the adoption of technologically advanced devices, the availability of products at reasonable prices, and the presence of several industry players will contribute to the regional growth.
Some of the industry players contributing to the needle free devices landscape are INJEX Pharma AG, Antares Pharma, Verdict Media, PharmaJet, 3M, Inovio Pharmaceuticals, Valeritas, Zonenix, and others. These players are adopting several initiatives like long-term collaborations, acquisitions, and mergers to foster the growth of needle free devices. On September 14, 2021 for instance, Pharmajet announced its association with Scarcell to administer needle free COVID-19 vaccination.
COVID-19 has a mixed impact on the market. The scarcity of raw materials and the rising inflation in plastic and raisin deeply impacted the market growth. Countrywide lockdowns leading to transport restrictions affected the supply chain management of the products.
However, recent developments like the introduction of the ZyCOV-D vaccine, the three-dose needle free vaccine for kids, in August 2021 is likely to boost the product demand. Moreover, the growing COVID complexities among the diabetic population leading to increased adoption of the product for insulin injection will further propel the market growth.
Market, By Technology
Market, By End-users
The above information is provided for the following regions and countries: